News from the world

14

Jul

China NMPA conducts management review of QMS for regulation of vaccine and drug GMP compliance

The National Medical Products Administration (NMPA) conducted its 2025 annual management review of the Quality Management System (QMS) for regulation of vaccine and drug Good Manufacturing Practice (GMP) compliance on June 30. NMPA Commissioner Huang Guo presided over the meeting and fully affirmed the suitability, adequacy and effectiveness of the NMPA's QMS in both areas...[NMPA]

17

Jul

Inside Pharma’s Push for More Resilient Supply Chains

Industry leaders from Samsung Biologics and Fujifilm Biotechnologies discuss how regional manufacturing,...

17

Jul

US FDA CDER plans new guidance on AI, electronic safety report submissions, and more

The US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) has...

16

Jul

EU DG SANTE and EMA sign Working Arrangement with New Zealand Ministry of Health

DG SANTE and the European Medicines Agency (EMA) have signed a Working Arrangement with New Zealand Ministry...

15

Jul

Riforma farmaceutica. Via libera della Commissione Sanità del Senato

 Le poche modifiche approvate non cambiano l'impianto della riforma. L’articolo 3 a...